Andrew Left

U.S. Attorney Bill Essayli slammed Citron Research founder Andrew Left on Tuesday, stating, “Short selling is not a crime. He made misleading statements to move the stock so that he could quickly trade on it for his gain. In essence, he cheated.” In his X post, Essayli said Left was...

A federal jury’s criminal conviction of Citron Research founder Andrew Left has sent shockwaves through Wall Street, sparking intense debate over the future boundaries of activist short selling and independent market research. The Precedent-Setting Verdict Left, 55, was found guilty of...

Citron Research founder Andrew Left renewed his aggressive short campaign against Strategy Inc. (NASDAQ:MSTR) on Thursday, dismissing the company's complex financial architecture as "nonsense" after the firm reported a staggering $12.4 billion fourth-quarter loss. Jargon Vs. Reality The critique...

Citron Research, led by Andrew Left, is doubling down on its quantum computing pick, noting that it has successfully transitioned from being a conceptual science project to a commercial reality. This Is No Longer ‘A Science Project’ On Monday, in a post on X, Left reiterated his bullish...

Investor Andrew Left’s Citron Research says a cybersecurity stock is being “deeply mispriced” by investors, while assigning a price target that’s more than double its current levels. This Company ‘Must Be Rerated’ On Thursday, in a post on X, Citron Research made...

Short seller Citron Research, led by Andrew Left, made a prediction one year ago. The firm bet on Bitcoin (CRYPTO: BTC), but against the Bitcoin treasury company Strategy Inc (NASDAQ:MSTR). Here are the results of the trade. Citron Bets Against MicroStrategy Citron Research, best known for betting...

Andrew Left’s Citron Research is calling out a little-known nuclear contractor, which it says is about to become one of the most strategically significant companies in the United States under the Trump administration. The Little-Known Nuclear Contractor On Wednesday, in a post on X, Citron...

Palantir Technologies Inc. (NYSE:PLTR) stock fell more than 11% this week, even as the software company reported better-than-expected quarterly results, prompting CEO Alex Karp to criticize those betting against the stock, calling it “market manipulation.” Check out the current price of...

As chipmaker NVIDIA Corp. (NASDAQ:NVDA) surges past $5 trillion in market capitalization, several prominent analysts have reacted to the stock’s unrelenting rally, amid growing concerns regarding its sustainability and speculations of an AI bubble. 56x Return In Seven Years Investor Andrew...

Hedge fund manager George Noble posted a bold criticism of Opendoor Technologies, Inc.’s (NASDAQ:OPEN) latest product rollouts in a social media post on Wednesday night.  OPEN stock is moving. See the real-time price action here.  Earlier on Wednesday, Opendoor CEO Kaz Nejatian...

Hedge fund manager George Noble criticized iBuying platform Opendoor Technologies Inc. (NASDAQ:OPEN), which has seen a monumental 1,776% rally since hitting an all-time low in late June. The Business Model ‘Does Not Work’ In a post on X, Noble, who has founded two billion-dollar hedge...

Famed short-seller Andrew Left of Citron Research is taking a victory lap on a bullish call, celebrating his firm’s early bet on AI infrastructure company Nebius Group NV (NASDAQ:NBIS). In a post on X Tuesday, Left recalled his firm's December 2024 thesis, noting it was "Just a pat on the...

Citron Research, led by famed short-seller Andrew Left, targeted Opendoor Technologies, Inc. (NASDAQ:OPEN) in a social media post on Friday. Opendoor investors shrugged off the attack, and the stock climbed.  OPEN stock is running again. See the real-time chart here.  Citron called Opendoor...

Palantir Technologies (NASDAQ:PLTR) stock has gained more than 100% year-to-date, hitting new all-time highs in August before a recent pullback. After a short seller questioned the company's valuation, Benzinga polled readers to learn when investors might see all-time highs again. What Happened:...

UnitedHealth Group (NYSE:UNH) stock is soaring Friday morning with a handful of large investors revealing long positions in the health insurance company via quarterly 13F filings. Among the investors in UnitedHealth Group stock is short seller Andrew Left of Citron Research, who is best known for...